CPAP Effects on Atherosclerotic Plaques in Patients with Sleep Disordered Breathing and Coronary Artery Disease.

Dohi Tomotaka0 个研究点目标入组 100 人开始时间: 2019年3月14日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients over 20 years of age and under 75 years of age
•2. Patients who have been diagnosed with stable coronary heart disease
•3. Patients with 3%ODI >15 events/h
•4. Successful PCI for significant coronary stenotic lesion under IVUS guidance and patients having non-calcified plaque with maximal plaque burden > 40% of the non-culprit lesion segment detected by IVUS
•5. Patients who agree to be enrolled in the trial, providing signed written informed consent standing after having received enough explanation on participating to this study at the agreement acquisition.

•1.Patients under 20 years of age and over 75 years of age
•2.Patients who have been required coronary bypass surgery
•3.Patients with malignant disease who have been required to chemotherapy
•4.Patients who have been required to be treated with invasive surgery
•5.Patients with renal insufficiency (serum creatinine >2.0 mg/dL) or with hemodialysis
•6.Patients with respiratory failure who have been required oxygen therapy
•7.Patients treated with CPAP therapy
•8.Patients with New York Heart Association class II, III, or IV heart failure
•9.Patients with hypersomnia requiring urgent treatment (defined as an Epworth Sleepiness Scale [ESS] score=>18)
•10.Patients recognized as inadequate by attending physician

发起方

Dohi Tomotaka